Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $9.99 and traded as low as $8.68. Bavarian Nordic A/S shares last traded at $8.68, with a volume of 10,655 shares traded.
Bavarian Nordic A/S Stock Down 0.5 %
The firm has a market capitalization of $2.06 billion, a P/E ratio of 12.64 and a beta of 1.65. The business has a 50-day moving average price of $9.52 and a 200-day moving average price of $9.99.
Bavarian Nordic A/S Company Profile
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Featured Articles
- Five stocks we like better than Bavarian Nordic A/S
- 3 Monster Growth Stocks to Buy Now
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- The 3 Best Fintech Stocks to Buy Now
- 2 Drone Stocks Surging from Increased Media Attention
- 3 REITs to Buy and Hold for the Long Term
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Bavarian Nordic A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic A/S and related companies with MarketBeat.com's FREE daily email newsletter.
